The efficacy and safety of azithromycin in asthma: A systematic review.
adverse events
asthma
azithromycin
life quality
lung function
systematic review
Journal
Journal of cellular and molecular medicine
ISSN: 1582-4934
Titre abrégé: J Cell Mol Med
Pays: England
ID NLM: 101083777
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
08
04
2018
revised:
30
07
2018
accepted:
26
08
2018
pubmed:
21
1
2019
medline:
22
7
2020
entrez:
21
1
2019
Statut:
ppublish
Résumé
Azithromycin is a potential therapeutic choice for asthma control, which is a heterogeneous airway inflammatory disease. Because of variable findings, we intend to evaluate the therapeutic effect and safety of azithromycin in asthma. Databases, including PubMed, EMBASE, Cochrane, and CNKI until 31 December 2017, were searched to identify available randomised controlled trials regarding azithromycin treatment for asthma. We identified seven studies involving 1520 cases that met our criteria. The mean difference for lung function (FEV
Identifiants
pubmed: 30661297
doi: 10.1111/jcmm.13919
pmc: PMC6378181
doi:
Substances chimiques
Anti-Bacterial Agents
0
Azithromycin
83905-01-5
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1638-1646Informations de copyright
© 2018 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Références
Pediatr Res. 2007 Oct;62(4):483-8
pubmed: 17667842
Lancet. 2012 Aug 18;380(9842):627-9
pubmed: 22901872
PLoS Clin Trials. 2006 Jun;1(2):e11
pubmed: 16871333
Lancet. 2002 Sep 28;360(9338):978-84
pubmed: 12383667
Pharmacol Res. 2011 May;63(5):389-97
pubmed: 21315154
J Am Board Fam Med. 2012 Jul-Aug;25(4):442-59
pubmed: 22773713
Allergy Asthma Proc. 2007 Mar-Apr;28(2):194-8
pubmed: 17479604
Lancet. 2013 Oct 19;382(9901):1360-72
pubmed: 24041942
J Pharmacol Exp Ther. 2013 Apr;345(1):76-84
pubmed: 23359665
N Engl J Med. 2011 Aug 25;365(8):689-98
pubmed: 21864166
Eur J Pharmacol. 2002 Aug 30;450(3):277-289
pubmed: 12208321
Lancet. 2015 Sep 12;386(9998):1086-96
pubmed: 26383000
Life Sci. 2017 Feb 1;170:1-8
pubmed: 27916734
Thorax. 2013 Apr;68(4):322-9
pubmed: 23291349
J Cell Mol Med. 2019 Mar;23(3):1638-1646
pubmed: 30661297
Lancet. 2017 Aug 12;390(10095):659-668
pubmed: 28687413
JAMA Intern Med. 2016 Nov 1;176(11):1630-1637
pubmed: 27653939
Chest. 2009 Aug;136(2):498-506
pubmed: 19429717
Pulm Pharmacol Ther. 2016 Feb;36:37-45
pubmed: 26778828
Br J Pharmacol. 2012 Mar;165(5):1348-60
pubmed: 21726210
Int Arch Allergy Immunol. 2011;156(2):179-86
pubmed: 21597298
Ther Adv Respir Dis. 2011 Dec;5(6):377-86
pubmed: 21890536
Eur Respir J. 2013 Nov;42(5):1412-5
pubmed: 24036246